Book ChapterOPEN ACCESS

Imaging and Therapy Against Hypoxic Tumors with 64Cu-ATSM

  • Fujibayashi Y
  • Yoshii Y
  • Furukawa T
  • et al.
Springer Singapore, (2020), 285-292
DOI: 10.1007/978-981-13-7908-6_29
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hypoxia in tumors is known to contribute to the malignant characteristics such as therapy resistance and metastatic potential. Cu-diacetyl-bis (N 4-methylthiosemicarbazone) (Cu-ATSM), labeled with several Cu radioisotopes (60Cu, 62Cu and 64Cu) is a potential PET...

Cite

CITATION STYLE

APA

Fujibayashi, Y., Yoshii, Y., Furukawa, T., Yoshimoto, M., Matsumoto, H., & Saga, T. (2020). Imaging and Therapy Against Hypoxic Tumors with 64Cu-ATSM. In Make Life Visible (pp. 285–292). Springer Singapore. https://doi.org/10.1007/978-981-13-7908-6_29

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free